Intervention not reported
Any depression Multiple measures used. CES‐D (Blanchard 1996;McCorkle 2007). POMS Depression subscale (Bultz 2000). HADS‐D (Nicolaisen 2018; Robertson 2016). Higher scores indicate higher levels of depression. Folllow‐up: Three to six months post‐... · informal caregivers of people affected by cancer
1 finding from 1 review
Intervention not reported
Any anxiety STAI‐S (Blanchard 1996). POMS Anxiety subscale (Bultz 2000; Campbell 2007). HADS‐A (Nicolaisen 2018; Robertson 2016). Additional study (reported in comments section): SCL‐90‐R Anxiety subscale (Heinrich 1985). Higher scores indicate hi... · informal caregivers of people affected by cancer
1 finding from 1 review
Intervention not reported
Any anxiety STAI‐S (Blanchard 1996). POMS Anxiety subscale (Bultz 2000). HADS‐A (Nicolaisen 2018; Robertson 2016). Higher scores indicate higher levels of anxiety. · informal caregivers of people affected by cancer
1 finding from 1 review
Intervention not reported
Caregiver physical health status Studies (reported in comments section): Multilevel Assessment Instrument Total Score (Budin 2008).*** SF12 Physcial Component Summary Score (Northouse 2007). Higher scores indicate higher levels of physical health ... · informal caregivers of people affected by cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
General well‐being
4 findings from 1 review
no estimate extracted
744 participants
Very low
no estimate extracted
129 participants
Very low
no estimate extracted
547 participants
Low
Show 1 more finding
Well‐being Higher score better Mid‐term cRCT + RCT Off the job/interaction training
1 finding from 1 review
Well being: Short Form ‐36
2 findings from 1 review
no estimate extracted
337 participants
Very low
no estimate extracted
143 participants
Very low
Well‐being Higher score better Mid‐term cRCT + RCT Off the job/interaction training
1 finding from 1 review
Tear film stability · people with dry eyea
Combined oral omega‐3 and omega‐6 PUFAs showed no clear difference in change in tear film stability, measured using tear break‐up time… compared with placebo (moderate certainty).
1 finding from 1 review
Aqueous tear production · people with dry eyea
Oral long‐chain omega‐3 PUFAs showed no clear difference in change in Schirmer test (aqueous tear production, measured in mm/5… compared with oral omega‐6 PUFAs (low certainty).
1 finding from 1 review
Tear film stability · people with dry eyea
1 finding from 1 review
Aqueous tear production · people with dry eyea
Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) showed no clear difference in change in Schirmer test (aqueous tear production, measured in mm/5… compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Tear film stability · people with dry eyea
1 finding from 1 review
Aqueous tear production · people with dry eyea
Combined oral omega‐3 and omega‐6 PUFAs showed no clear difference in schirmer test (aqueous tear production, measured in mm/5 min, with… compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Achievement of at least 50% reduction in headache severity Post‐treatment Higher scores indicate more children with reduced headache · children or adolescents with headaches
It is very uncertain whether the intervention changes achievement of at least 50% reduction in headache severity… (very low certainty).
1 finding from 1 review
Pharmacy user health‐related behaviour3 (Higher scores indicate a better outcome) · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
2138 participants
Moderate
Pharmacy user quality of life6 (Higher scores indicate better quality of life) · community pharmacy workers (examples pharmacists, counter assistants etc), community pharmacy users
1 finding from 1 review
no estimate extracted
2687 participants
Moderate
Pain at 6 months or more; all doses Assessed by change from baseline, using a 0‐ to 100‐mm VAS, where higher scores indicate more pain) · people with diabetic peripheral neuropathy
1 finding from 1 review
Symptom quality and severity Assessed by NSS score (range of possible scores 0 to 9; higher scores indicate more symptoms) · the treatment of diabetic peripheral neuropathy
1 finding from 1 review
Intervention not reported
Disability (measured by the Glasgow Outcome Scale; higher score is better) · adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
1 finding from 1 review